Kryvyi Rih Oncology Dispensary / Кривий Ріг Онкологічний диспансер
Industry / private company
Location:
Kryvyi Rih,
Ukraine (UA)
Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study (2023)
Hurvitz SA, Bardia A, Quiroga V, Park YH, Blancas I, Alonso-Romero JL, Vasiliev A, et al.
Journal article